Cambridge Investment Research Advisors, Inc. Cerus Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,860 shares of CERS stock, worth $34,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,860
Previous 17,220
21.14%
Holding current value
$34,419
Previous $30,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CERS
# of Institutions
159Shares Held
146MCall Options Held
48.6KPut Options Held
8.7K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$34.3 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$32.1 Million0.33% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$22.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$17.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$13.7 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $292M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...